CIK 0001674930
- Accelerated filer
Fulgent Genetics, Inc.
Sign in to watch- Ticker
- FLGT
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812621304
- Phone
- +1 626-350-0537
- Business address
- 4399 SANTA ANITA AVE, EL MONTE, CA, 91731
- Former names
- Fulgent Diagnostics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $117,132
- in 4 filings
Net −$117,132. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-09-30 | BOLGER JOHN C Director | Grant or award · Issuer Stock Option (Right to Buy) | +2,631 | 2,631 | ||
| 2016-09-30 | Gao Hanlin Chief Scientific Officer | Returned to the company | −13,434,211 | 0 | ||
| 2016-09-30 | Gao Hanlin Chief Scientific Officer | Grant or award | +1,767,659 | 1,767,659 | ||
| 2016-09-30 | Xi Long USA, Inc. 10% owner | Other acquisition | +2,025,623 | 2,025,623 | ||
| 2016-09-30 | Xi Long USA, Inc. 10% owner | Other disposition · Predecessor Class D-2 Preferred Units | −15,394,737 | 0 | ||
| 2016-09-30 | Yen Yun Director | Returned to the company | −4,000,000 | 0 | ||
| 2016-09-30 | Yen Yun Director | Grant or award | +526,315 | 526,315 | ||
| 2016-09-30 | KIM PAUL CFO and Treasurer | Returned to the company | −500,000 | 0 | ||
| 2016-09-30 | KIM PAUL CFO and Treasurer | Returned to the company | −2,500,000 | 0 | ||
| 2016-09-30 | KIM PAUL CFO and Treasurer | Grant or award | +394,736 | 394,736 | ||
| 2016-09-30 | Hsieh Ming President and CEO | Grant or award | +5,444,944 | 5,444,944 | ||
| 2016-09-30 | Hsieh Ming President and CEO | Grant or award | +1,315,789 | 1,315,789 | ||
| 2016-09-30 | Hsieh Ming President and CEO | Purchase | +1,000,000 | $9.00 | $9.0M | 6,444,944 |
| 2016-09-30 | Hsieh Ming President and CEO | Returned to the company · Predecessor Class D-1 Preferred Units | −41,381,579 | 0 | ||
| 2016-09-30 | Hsieh Ming President and CEO | Returned to the company · Predecessor Class D-1 Preferred Units | −10,000,000 | 0 | ||
| 2016-08-12 | KIM PAUL CFO and Treasurer | Grant or award | +500,000 | 500,000 | ||
| 2016-06-22 | BOLGER JOHN C Director | Grant or award · Predecessor Unit Option (Right to Buy) | +20,000 | 20,000 | ||
| 2016-05-13 | Gao Hanlin Chief Scientific Officer | Sale | −2,565,789 | $1.17 | $3.0M | 13,434,211 |
| 2016-05-13 | Hsieh Ming President and CEO | Grant or award | +1 | $0.00 | $0 | 1 |
| 2016-05-13 | Hsieh Ming President and CEO | Sale · Predecessor Class D-1 Preferred Units | −4,618,421 | $1.17 | $5.4M | 41,381,579 |
Page 30 of 31 · 601 trades